Українська English

ISSN 2522-9028 (Print)
ISSN 2522-9036 (Online)
DOI: https://doi.org/10.15407/fz

Fiziologichnyi Zhurnal

is a scientific journal issued by the

Bogomoletz Institute of Physiology
National Academy of Sciences of Ukraine

Editor-in-chief: V.F. Sagach

The journal was founded in 1955 as
1955 – 1977 "Fiziolohichnyi zhurnal" (ISSN 0015 – 3311)
1978 – 1993 "Fiziologicheskii zhurnal" (ISSN 0201 – 8489)
1994 – 2016 "Fiziolohichnyi zhurnal" (ISSN 0201 – 8489)
2017 – "Fiziolohichnyi zhurnal" (ISSN 2522-9028)

Fiziol. Zh. 2008; 54(4): 23-29

Antioxidants prevent experimental hemiparkinsonism in rats

S.A. Talanov, V.F. Sahach.

    O.O. Bogomoletz Institute of Physiology, NationalAcademy of Sciences of Ukraine, Kyiv



Abstract

We studied the influence of antioxidants (trolox, melatonin and coenzyme Q10) on 6-hydroxydopamine-induced degeneration in the substantia nigra dopaminergic neurons from the left brain hemisphere. In rats, the level of unilateral degeneration of nigrostriatal dopaminergic system was estimated on the base of an intensity of rotation movements which were contralateral to denervated hemishere and resulted from systemic injections of a dopamine receptor agonist apomorphine. It has been shown that all tested antioxidants reduced a number of animals with apomorphine-induced behavioral asymmetry in a different de- gree: coenzyme Q10) reduced it twofold, trolox – fivefold and melatonin – sevenfold. We suggest that a neuroprotective ef- fects of trolox, melatonin and coenzyme Q10) are associated with their ability to block the mitochondrial pore openings in the nervous cells under exploration, and this is the way to prevent apoptotic death. An oxidative stress has been proved to take part in the apoptosis in dopamine-producing neurons in the sub- stantia nigra, and tested antioxidants have been shown to be effective in preventing neurodegeneration.

Full text: (PDF, in Ukrainian)

References

  1. Донченко Г.В. Биохимия убихинона /Q/. – К.: Наук. думка, 1988. – 240 с.
  2. Донченко Г.В., Кучменко О.Б., Петухов Д.М. Біохімічні властивості і функціональна роль убихи- нону (Q). Практичні аспекти застосування // Укр. біохім. журн. – 2005. – 70, № 5. – С. 24–36.
  3. Запрометов М.Н. Фенольные соединения. – М.: Наука, 1993.
  4. Крыжановский Г.Н., Никушин Е.В. и др. Перекисное окисление липидов у больных болезнью Паркинсона // Пробл. старения и долголетия – 1993. – № 1. – С.A. Таланов, В.Ф. Сагач
  5. 82ISSN 0201-8489 Фізіол. журн., 2008, Т. 54, № 4 C. 47–50.
  6. Надточий С.Н., Шиманская Т.В., Сагач В.Ф. Предупреждение постреперфузионных нарушений функции сердца с помощью мелатонина // Архив клин. и эксперим. медицины. – 2003. – 12, № 1. – С. 71–72.
  7. Побежимова Т.П., Войникова В.К. Биохимические и физиологические аспекты функционирования убихинона // Биол. мембраны. – 1999. – 16, № 5. – С. 485–491.
  8. Сагач В.Ф., Вавілова Г.Л., Рудик О.В., Добровольский Ф.В., Шиманська Т.В. Інгібування мітохондріальної пори як один із механізмів кардіопротекторної дії коензиму Q 10 // Фізіол. журн. – 2007. – 53, № 4. – C. 34–41.
  9. Сагач В.Ф., Шиманська Т.В., Надточій С.Н. Попередження постреперфузійних порушень серця та неефективного використання кисню за допомогою інгібіторів мітохондріальної пори // Там само. – 2002. – 48, № 6. – С. 3–9.
  10. 9. Andrabi S.A., Sayeed I., Siemen D. еt al. Direct inhibition of the mitochondrial permeability // FASEB J. – 2004. – 18, №7. – P. 869–871.
  11. 10. Andrew R., Watson D.G., Best S.A. et al. The deter- mination of hydroxydopamines and other trace amines in the urine of parkinsonian patients and normal controls // Neurochem. Res. – 1993. – 18. – P. 1175–1177.
  12. Azzi A., Aratri E., Boscoboinik D. et al. Molecular basis of alpha-tocopherol control of smooth muscle cell proliferation // Biofactors. – 1998. – 7, №1–2. – P. 3–14.
  13. Cassarino D.S., Bennet J.P. Jr. An evaluation of the role of mitochondria in neurodegenerative disease: mitohond- rial mutations and oxidative pathology protective nuclear responses, and cell death in neurodegeneration // Brain Res. Brain Res. Rev. – 1999. – 29. – P. 1–25.
  14. Chiueh C.C., Krishna G. et al. Intracranial microdialysis of salicylic acid to detect hydroxyl radical generation through dopamine autooxidation in the caudate nucleus: effect of MPP+ // Free Rad. Biol. Med. – 1992. – 13. – P. 581–583.
  15. Chow C.K., Ibrahim W., Wei Z., Chan A.C. Vitamin E regulates mitochondrial hydrogen peroxide generation // Free Radic. Biol. Med. – 1999. – 27, № 5–6. – P. 580–587.
  16. Crane F.L. Biochemical functions of coenzyme Q10 // J. Amer. Coll. Nutr. – 2001. – 20, № 6. – Р. 591–598.
  17. Curtius H.C., Wolfensberger M., Steinmann B. et al. Mass fragmentography of dopamine and 6-hydroxy- dopamine. Application to the determination of dopam- ine in human brain biopsies from the caudate nucleus // J. Chromatogr. – 1974. – 99. – P. 529–540.
  18. Foley P., Riederer P. Influence of neurotoxins and oxi- ative stress on the onset and progression of Parkinson’s disease // J. Neurol. – 2000. – 247. – Suppl. 2. – P. II/ 82–II/94.
  19. Frei B., Kim M.C., Ames B.N. Ubiquinol-10 is an ef- fective lipid-soluble antioxidant at physiological concentrations // Proc. Nat. Acad. Sci. USA. – 1990. – 87, № 12. – P. 4879–4883.
  20. 19. Han J., Cheng F.C., Yang Z., Dryhurst G. Inhibitors of mitohondrial respiration, iron (II), and hydroxyl radical evoke release and extracellular hydrolysis of glutathione in rat striatum and substantia nigra: potential implication to Parkinson’s disease // J. Neuroche. – 1999. – 73. – P. 1683–1695.
  21. 20. Jenner P., Olanow C.W. Оxidative stress аnd the patho- genesis of Parkinson’s disease // Neurology. – 1996. – 47, № 6, Suppl. 3. – P. 161–170.
  22. Kaul N., Siveski-Iliskovic N., Thomas T.P. et al. Probucol improves antioxidant activity and modulates development of diabetic cardiomyopathy // Nutrition. – 1995. – 11, № 5, Suppl. – P. 551–554.
  23. Langston J.W. MPTP neurotoxity: an overview and characterization of phases of toxicity // Life Sci. – 1985. – 36. – P. 201–206.
  24. Leeuwenburg C., Phaneuf S. Cytochrom c release from mitochondria in the aging heart: a possible mechanism for apoptosis with age // Amer. J. Physiol Reg. Int. Comp. Physiol. – 2002. – 282. – P. R423–R430.
  25. Liu X., Kim C.M., Yang J. et al. Induction of apoptotic program in cell-free extracts: requirement for ATP and cytochrome C // Cell. – 1996. – 86. – P. 147–157.
  26. Marsden C.D., Olanov C.W. The causes of Parkinson’s disease are being unraveled and rational neuroprotective therapy is close to reality // C.W. Olanow., P. Jenner eds. Beyong the decade of brain. – Kent: Wells Medi- cal Limited. – 1998. – 3. – P. 365-375.
  27. Mayo J.C. Sainz R.M. Uria H. Melatonin prevents apoptosis induced by 6-hydroxydopamine in neuronal cells: implications for Parkinson’s disease // J. Pineal. Res. – 1998. – 24, № 3. – P. 179–192.
  28. Menedez-Pelaez A., Reiter R.J. Subcellular localization of melatonin: evidence suggests primarily a nuclear location // Ibid. – 1993. – 15. – P. 59–69.
  29. Meydani S.N., Beharka A.A. Recent developments in vitamin E and immune response // Nutr Rev. – 1998. – 56, № 1 (Pt 2). – P. S49–S58.
  30. 29. Moshizuki H., Goto G., Mori H., Mizuno Y. Histochemi- cal detection of apoptosyis in Parkinson’s disease // J. Neurol. Sci. – 1996. – 120. – P. 120–123.
  31. 30. Moshizuki H., Mori H., Mizuno Y. Apoptosis in neurodegenerative disorders // J. Neural. Transm. Suppl. – 1997. – 50. – P. 125–240.
  32. Overvad K., Diamant B., Holm L. Coenzyme Q 10 in health and disease // Eur. J. Clin. Nutr. – 1999. – 53, № 10. – Р. 764–770.
  33. Park T.H., Known O.S., Park S.Y. et al. N-methylated beta-carolines protect PC12 cells from cytotoxic effect of MPP+ by attenuation of mitochondrial membrane permeability change // Neurosci. Res. – 2003. – 46, № 3. – P. 349–358.
  34. Reiter R.J., Poeggeller B., Tan D.X. et al. Antioxidant capacity of melatonin: a novel action not requiring a receptor // Neuroendocrin. Lett. – 1993. – 8. – P. 103–116.
  35. Reiter R.J., Tan D.X., Cabrera J. et al. The oxidant/ antioxidant network: role of melatonin // Biol. Signals Recept. – 1999. – 8. – P. 56–63.
  36. Rosengurt E. Autocrine loops, signal trunsduction, and cell cycle abnormalites in the molecular biology of lung cancer // Curr. Opin. Oncol. – 1999. – 11. P. 116–122.
  37. Sagach V.F., Scrosati M., Fielding J. et al. The water- soluble vitamin E analogue Trolox protects against is- chaemia/reperfusion damage in vitro and ex vivo. A comparison with vitamin E // Pharmacol. Res. – 2002. – 45. – P. 435–439.
  38. Talanov S.A., Oleshko N.N., Tkachenko M.N., Sagach V.F. Pharmacoprotective influences on different links of the mechanism underlying 6-hydroxydopamine-induced degeneration of nigro-striatal dopaminergic neurons // Neurophysiology. – 2006. – 38, № 2. – P. 150–156.
  39. Tatton W.G., Chalmers-Redman R.M., Ju W.Y., Waida J., Tatton N.A. Apoptosis in neurodegensrative disieders: potential for therapy by modifying gene transcription // J. Neural Transm. Suppl. – 1997. – 49. – P. 245–268.
  40. 39. Willner U., Kornhuber J., Weller M. Cell death and apoptosis regulating proteins in Parkinson’s disease // Acta Neuropathol. (Berl.) – 1999. – 97. – P. 408–412.
  41. 40. Yamauchi R. Free radical scavenging reactions of б-toco- pherol during the autooxidation of methyl linoleate in bulk phase // JAF Chem. – 1995. – 43. – P. 1455–1465.
  42. Zorov D.B., Filburn C.R., Klotz L.O. et al. Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the motochond- rial permeability transition in cardiac myocytes // J. Exp. Med. – 2000. – 192, № 7. – P. 1001–1014.
© National Academy of Sciences of Ukraine, Bogomoletz Institute of Physiology, 2014-2024.